WHO ICTRP trial
Clinical Trial on the Efficacy and Safety of Ganoderma Spore Powder in Treating…
ITMCTR2025000329 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Not Recruiting
Key facts
| Trial ID | ITMCTR2025000329 |
|---|---|
| Public title | Clinical Trial on the Efficacy and Safety of Ganoderma Spore Powder in Treating Hyperlipidemia of the Type with Phlegm-Turbidity Obstruction |
| Scientific title | Clinical Trial on the Efficacy and Safety of Ganoderma Spore Powder in Treating Hyperlipidemia of the Type with Phlegm-Turbidity Obstruction |
| Primary sponsor | Zhejiang Hospital |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Pilot clinical trial |
| Countries | China |
| Conditions | Hyperlipidemia of the Type with Phlegm-Turbidity Obstruction |
| Interventions | Treatment Group:Atorvastatin Calcium 20mg.qn combined with Ganoderma Spore Powder 2g per dose BID (twice daily);Control Group:Atorvastatin Calcium 20mg.qn combined with placebo |
| Registration date | Feb 18, 2025 |
| Target size | Treatment Group:30;Control Group:30 |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: